Your Messages Inbox
Your Article Summary
See Latest ArticlesAccess to HIV medication
Boehringer Ingelheim, 10/08/09
Boehringer Ingelheim has repeatedly and clearly stated that patents must not prevent access from life–saving drugs for HIV patients living in resource limited settings. In line with this and in order to accelerate access to anti–retroviral medicines, the company has initiated non–assert declarations in May 2007, well before the idea of the UNITAID patent pool was conceived. The declarations have been welcomed by all stakeholders including NGOs such as medicines sans frontieres, patient organisations and the press.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
AstraZeneca and the University of Virginia sign strategic research collaboration to develop novel treatments for cardiovascular disease
AstraZeneca, 12/16/09
Sanofi Pasteur expands study of vaccine against Clostridium difficile into the U.S.
Sanofi-aventis, 12/16/09
Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study
Amylin Pharmaceuticals, 12/16/09
Article Search
Sponsor